Fluoxetine
Back to searchMolecule Structure
Scientific Name
Fluoxetine
Description of the Drug
Fluoxetine is a selective serotonin reuptake inhibitor used to treat major depressive disorder, bulimia, OCD, premenstrual dysphoric disorder, panic disorder, and bipolar I.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00472
http://www.drugbank.ca/drugs/DB00472
Brand Name(s)
Not Available
Company Owner(s)
Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, Actavis Mid Atlantic Llc, Mylan Pharmaceuticals Inc, Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Akorn Operating Co Llc, Torrent Pharmaceuticals Ltd, Micro Labs Ltd, Teva Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Serotonin transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL228 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL8353 | ||||
| PharmGKB | PA449673 | ||||
| Human Metabolome Database | HMDB0014615 | ||||
| DrugBank | DB00472 | ||||
| PubChem: Thomson Pharma | 14874184 | ||||
| PubChem | 3386 | ||||
| NMRShiftDB | 70114036 | ||||
| LINCS | LSM-1449 | ||||
| Nikkaji | J292.434J | ||||
| BindingDB | 30130 | ||||
| EPA CompTox Dashboard | DTXSID7023067 | ||||
| DrugCentral | 1209 | ||||
| Brenda | 145052 | 4645 | 145965 | ||
| ChemicalBook | CB3361058 | ||||
| Guide to Pharmacology | 203 | ||||
| rxnorm | SARAFEM | PROZAC | SYMBYAX | FLUOXETINE | FLUOXETINE HYDROCHLORIDE |
| ChEBI | 86990 |
